OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS

Abstract. A new role of B-cells in pathogenesis of multiple sclerosis (MS), their relations with B-cells indevelopment of inflammation and probable mechanisms of advanced therapeutic intervention in order to reach B-cell depletion are subject to discussion in present article. Here we describe a clin...

Full description

Saved in:
Bibliographic Details
Main Authors: E. P. Evdoshenko, A. L. Maslyancky, L. G. Zaslavsky, A. A. Skoromets, I. S. Ziuzgin, O. E. Riabykina, N. A. Totolian, E. E. Zueva, S. V. Lapin, Areg A. Totolian
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/144
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract. A new role of B-cells in pathogenesis of multiple sclerosis (MS), their relations with B-cells indevelopment of inflammation and probable mechanisms of advanced therapeutic intervention in order to reach B-cell depletion are subject to discussion in present article. Here we describe a clinical case of MS with a resistant clinical course, and results of anti B-cell treatment. To attain maximal clinical effect, a novel therapeutic regimen (a combination of rituximab and mitozantrone) was applied. Clinical, radiological and laboratory methods were used to substantiate the efficiency of treatment.
ISSN:1563-0625
2313-741X